{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:22:07Z","timestamp":1794543727798,"version":"4.9.1"},"reference-count":48,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10,28]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glycosylation of the surface immunoglobulin (Ig) variable region is a remarkable follicular lymphoma\u2013associated feature rarely seen in normal B cells. Here, we define a subset of diffuse large B-cell lymphomas (DLBCLs) that acquire N-glycosylation sites selectively in the Ig complementarity-determining regions (CDRs) of the antigen-binding sites. Mass spectrometry and X-ray crystallography demonstrate how the inserted glycans are stalled at oligomannose-type structures because they are buried in the CDR loops. Acquisition of sites occurs in \u223c50% of germinal-center B-cell\u2013like DLBCL (GCB-DLBCL), mainly of the genetic EZB subtype, irrespective of IGHV-D-J use. This markedly contrasts with the activated B-cell\u2013like DLBCL Ig, which rarely has sites in the CDR and does not seem to acquire oligomannose-type structures. Acquisition of CDR-located acceptor sites associates with mutations of epigenetic regulators and BCL2 translocations, indicating an origin shared with follicular lymphoma. Within the EZB subtype, these sites are associated with more rapid disease progression and with significant gene set enrichment of the B-cell receptor, PI3K\/AKT\/MTORC1 pathway, glucose metabolism, and MYC signaling pathways, particularly in the fraction devoid of MYC translocations. The oligomannose-type glycans on the lymphoma cells interact with the candidate lectin dendritic cell\u2013specific intercellular adhesion molecule 3 grabbing non-integrin (DC-SIGN), mediating low-level signals, and lectin-expressing cells form clusters with lymphoma cells. Both clustering and signaling are inhibited by antibodies specifically targeting the DC-SIGN carbohydrate recognition domain. Oligomannosylation of the tumor Ig is a posttranslational modification that readily identifies a distinct GCB-DLBCL category with more aggressive clinical behavior, and it could be a potential precise therapeutic target via antibody-mediated inhibition of the tumor Ig interaction with DC-SIGN\u2013expressing M2-polarized macrophages.<\/jats:p>","DOI":"10.1182\/blood.2021012052","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T18:14:24Z","timestamp":1629742464000},"page":"1570-1582","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":36,"title":["Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior"],"prefix":"10.1182","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1456-8997","authenticated-orcid":false,"given":"Giorgia","family":"Chiodin","sequence":"first","affiliation":[{"name":"School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2547-968X","authenticated-orcid":false,"given":"Joel D.","family":"Allen","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3163-608X","authenticated-orcid":false,"given":"Dean J.","family":"Bryant","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0031-6032","authenticated-orcid":false,"given":"Philip","family":"Rock","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine\/Hematopathology, University of Rochester Medical Center, Rochester, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8504-3231","authenticated-orcid":false,"given":"Enrica A.","family":"Martino","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine,"},{"name":"Division of Hematology, Azienda Policlinico-Ospedale Vittorio Emanuele, University of Catania, Catania, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3334-3387","authenticated-orcid":false,"given":"Beatriz","family":"Valle-Argos","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1814-2552","authenticated-orcid":false,"given":"Patrick J.","family":"Duriez","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7952-1268","authenticated-orcid":false,"given":"Yasunori","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isla","family":"Henderson","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4275-5562","authenticated-orcid":false,"given":"James S.","family":"Blachly","sequence":"additional","affiliation":[{"name":"Division of Hematology, The Ohio State University, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy J.","family":"McCann","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0972-2881","authenticated-orcid":false,"given":"Jonathan C.","family":"Strefford","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9232-5691","authenticated-orcid":false,"given":"Graham","family":"Packham","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5710-2839","authenticated-orcid":false,"given":"Teunis B. H.","family":"Geijtenbeek","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2366-9212","authenticated-orcid":false,"given":"Carl G.","family":"Figdor","sequence":"additional","affiliation":[{"name":"Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Wright","sequence":"additional","affiliation":[{"name":"Biometric Research Branch, Division of Cancer Diagnosis and Treatment;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Staudt","sequence":"additional","affiliation":[{"name":"Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5584-584X","authenticated-orcid":false,"given":"Richard","family":"Burack","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine\/Hematopathology, University of Rochester Medical Center, Rochester, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8066-8785","authenticated-orcid":false,"given":"Thomas A.","family":"Bowden","sequence":"additional","affiliation":[{"name":"Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1072-2694","authenticated-orcid":false,"given":"Max","family":"Crispin","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Southampton, Southampton, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0933-5021","authenticated-orcid":false,"given":"Freda K.","family":"Stevenson","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2211-1831","authenticated-orcid":false,"given":"Francesco","family":"Forconi","sequence":"additional","affiliation":[{"name":"School of Cancer Sciences, Cancer Research United Kingdom Southampton Centre, Faculty of Medicine,"},{"name":"Haematology Department, Cancer Care Directorate, University Hospital Southampton National Health Service Trust, Southampton, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6769","key":"2021102815242438100_B1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature."},{"issue":"25","key":"2021102815242438100_B2","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med."},{"issue":"4","key":"2021102815242438100_B3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell."},{"issue":"21","key":"2021102815242438100_B4","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-11-764332","article-title":"Genetics of diffuse large B-cell lymphoma","volume":"131","author":"Pasqualucci","year":"2018","journal-title":"Blood."},{"issue":"10","key":"2021102815242438100_B5","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7337","key":"2021102815242438100_B6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature."},{"issue":"2","key":"2021102815242438100_B7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet."},{"issue":"6","key":"2021102815242438100_B8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0092-8674(00)80373-6","article-title":"In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death","volume":"90","author":"Lam","year":"1997","journal-title":"Cell."},{"issue":"5","key":"2021102815242438100_B9","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.4049\/jimmunol.140.5.1695","article-title":"Idiotype vaccination leads to the emergence of a stable surface Ig-negative variant of the mouse lymphoma BCL1, with different growth characteristics","volume":"140","author":"George","year":"1988","journal-title":"J Immunol."},{"issue":"7657","key":"2021102815242438100_B10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature22353","article-title":"The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3\u03b2 inhibition","volume":"546","author":"Varano","year":"2017","journal-title":"Nature."},{"issue":"7718","key":"2021102815242438100_B11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41586-018-0290-0","article-title":"A multiprotein supercomplex controlling oncogenic signalling in lymphoma","volume":"560","author":"Phelan","year":"2018","journal-title":"Nature."},{"issue":"44","key":"2021102815242438100_B12","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1073\/pnas.1514944112","article-title":"Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens","volume":"112","author":"Young","year":"2015","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"8","key":"2021102815242438100_B13","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat Med."},{"issue":"7","key":"2021102815242438100_B14","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood.V99.7.2562","article-title":"Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma","volume":"99","author":"Zhu","year":"2002","journal-title":"Blood."},{"issue":"21","key":"2021102815242438100_B15","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood-2017-11-764365","article-title":"Critical influences on the pathogenesis of follicular lymphoma","volume":"131","author":"K\u00fcppers","year":"2018","journal-title":"Blood."},{"issue":"11","key":"2021102815242438100_B16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1182\/blood.2019002279","article-title":"IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution","volume":"135","author":"Odabashian","year":"2020","journal-title":"Blood."},{"issue":"10","key":"2021102815242438100_B17","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1074\/jbc.M602690200","article-title":"Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor","volume":"282","author":"Radcliffe","year":"2007","journal-title":"J Biol Chem."},{"issue":"1","key":"2021102815242438100_B18","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1038\/s41467-018-05770-9","article-title":"Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans","volume":"9","author":"Giovannone","year":"2018","journal-title":"Nat Commun."},{"issue":"10","key":"2021102815242438100_B19","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","article-title":"Exploitation of glycosylation in enveloped virus pathobiology","volume":"1863","author":"Watanabe","year":"2019","journal-title":"Biochim Biophys Acta, Gen Subj."},{"key":"2021102815242438100_B20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mam.2016.04.004","article-title":"Emerging roles of protein mannosylation in inflammation and infection","volume":"51","author":"Loke","year":"2016","journal-title":"Mol Aspects Med."},{"issue":"43","key":"2021102815242438100_B21","doi-asserted-by":"crossref","first-page":"18587","DOI":"10.1073\/pnas.1009388107","article-title":"Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins","volume":"107","author":"Coelho","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"16","key":"2021102815242438100_B22","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1182\/blood-2015-04-640805","article-title":"Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells","volume":"126","author":"Linley","year":"2015","journal-title":"Blood."},{"issue":"5","key":"2021102815242438100_B23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0092-8674(00)80693-5","article-title":"Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell."},{"issue":"3","key":"2021102815242438100_B24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1189\/jlb.71.3.445","article-title":"Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro","volume":"71","author":"Soilleux","year":"2002","journal-title":"J Leukoc Biol."},{"issue":"16","key":"2021102815242438100_B25","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1182\/blood-2015-04-640912","article-title":"DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma","volume":"126","author":"Amin","year":"2015","journal-title":"Blood."},{"issue":"31","key":"2021102815242438100_B26","doi-asserted-by":"crossref","first-page":"10987","DOI":"10.1073\/pnas.0505108102","article-title":"Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help","volume":"102","author":"Savelyeva","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"2021102815242438100_B27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-2141.2004.04816.x","article-title":"Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency","volume":"124","author":"Forconi","year":"2004","journal-title":"Br J Haematol."},{"issue":"15","key":"2021102815242438100_B28","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med."},{"issue":"1","key":"2021102815242438100_B29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s40425-019-0730-x","article-title":"Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies","volume":"7","author":"Xu-Monette","year":"2019","journal-title":"J Immunother Cancer."},{"issue":"1","key":"2021102815242438100_B30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/imr.12792","article-title":"Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment","volume":"291","author":"Young","year":"2019","journal-title":"Immunol Rev."},{"issue":"6","key":"2021102815242438100_B31","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.molimm.2007.10.009","article-title":"Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma","volume":"45","author":"McCann","year":"2008","journal-title":"Mol Immunol."},{"issue":"7","key":"2021102815242438100_B32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nsmb784","article-title":"Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR","volume":"11","author":"Guo","year":"2004","journal-title":"Nat Struct Mol Biol."},{"issue":"6","key":"2021102815242438100_B33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood-2016-05-718494","article-title":"Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling","volume":"129","author":"Myklebust","year":"2017","journal-title":"Blood."},{"issue":"4","key":"2021102815242438100_B34","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood-2005-01-0318","article-title":"Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody","volume":"106","author":"Tacken","year":"2005","journal-title":"Blood."},{"issue":"15","key":"2021102815242438100_B35","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1182\/blood-2011-04-346957","article-title":"Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation","volume":"118","author":"Tacken","year":"2011","journal-title":"Blood."},{"issue":"5","key":"2021102815242438100_B36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0092-8674(00)80694-7","article-title":"DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells","volume":"100","author":"Geijtenbeek","year":"2000","journal-title":"Cell."},{"issue":"3","key":"2021102815242438100_B37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/sj.leu.2404095","article-title":"Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event?","volume":"20","author":"McCann","year":"2006","journal-title":"Leukemia."},{"issue":"8","key":"2021102815242438100_B38","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.celrep.2018.07.080","article-title":"Site-specific glycosylation of virion-derived HIV-1 Env is mimicked by a soluble trimeric immunogen","volume":"24","author":"Struwe","year":"2018","journal-title":"Cell Rep."},{"key":"2021102815242438100_B39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.sbi.2017.03.008","article-title":"Structural principles controlling HIV envelope glycosylation","volume":"44","author":"Behrens","year":"2017","journal-title":"Curr Opin Struct Biol."},{"issue":"49","key":"2021102815242438100_B40","doi-asserted-by":"crossref","first-page":"E7890","DOI":"10.1073\/pnas.1611213113","article-title":"Substrate recognition and catalysis by GH47 \u03b1-mannosidases involved in Asn-linked glycan maturation in the mammalian secretory pathway","volume":"113","author":"Xiang","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"26","key":"2021102815242438100_B41","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.1016\/j.febslet.2006.10.009","article-title":"Specificity of DC-SIGN for mannose- and fucose-containing glycans","volume":"580","author":"van Liempt","year":"2006","journal-title":"FEBS Lett."},{"issue":"36","key":"2021102815242438100_B42","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"8","key":"2021102815242438100_B43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrc3774","article-title":"The tumour microenvironment in B cell lymphomas","volume":"14","author":"Scott","year":"2014","journal-title":"Nat Rev Cancer."},{"issue":"1","key":"2021102815242438100_B44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/imr.12983","article-title":"B cell\/stromal cell crosstalk in health, disease, and treatment: Follicular lymphoma as a paradigm","volume":"302","author":"Lamaison","year":"2021","journal-title":"Immunol Rev."},{"issue":"8","key":"2021102815242438100_B45","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41590-018-0156-5","article-title":"Second signals rescue B cells from activation-induced mitochondrial dysfunction and death","volume":"19","author":"Akkaya","year":"2018","journal-title":"Nat Immunol."},{"issue":"21","key":"2021102815242438100_B46","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood-2014-11-609404","article-title":"Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma","volume":"125","author":"Schneider","year":"2015","journal-title":"Blood."},{"issue":"1","key":"2021102815242438100_B47","doi-asserted-by":"crossref","first-page":"11676","DOI":"10.1038\/s41598-021-91112-7","article-title":"DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity","volume":"11","author":"Valle-Argos","year":"2021","journal-title":"Sci Rep."},{"issue":"3","key":"2021102815242438100_B48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1200\/JCO.18.01583","article-title":"Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma","volume":"37","author":"Ennishi","year":"2019","journal-title":"J Clin Oncol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/138\/17\/1570\/1830543\/bloodbld2021012052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/138\/17\/1570\/1830543\/bloodbld2021012052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T22:21:11Z","timestamp":1673130071000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/138\/17\/1570\/476653\/Insertion-of-atypical-glycans-into-the-tumor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":48,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2021,10,28]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021012052","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]}}}